The Autogenous Vaccines Market To Get On To The Magnanimous Mode At US$ 428 Million

18/feb/2021 18:02:21 persistencemarketresearch Contatta l'autore

Inadequacy of vaccines to combat increasing rare infectious diseases in livestock and companion animals is the key driving factor aiding the growth of the  autogenous vaccines market .

Autogenous vaccines are an efficient alternative to antibiotics that control and prevent infectious diseases. Improvements in animal health, decreased animal suffering, efficient food production, and reduction in the need for antibiotics are boosting the adoption of autogenous vaccines in the livestock industry.

Strategizing The Moves For The Next Decade? See Through Sample Of Autogenous Vaccines Market Report! 

Company Profiles

  • Newport Laboratories, Inc.
  • Elanco Animal Health
  • Ceva (Ceva Biovac)
  • Cambridge Technologies
  • Hygieia Biological Laboratories
  • Dyntec s. r. o
  • Phibro Animal Health Corporation
  • Huvepharma, Inc.
  • Deltamune
  • AniCon Labor GmbH
  • ACE Laboratory Services (Apiam Animal Health)

Increasing animal care spending and research & development activities in the veterinary biologics sector further favours the growth of the autogenous vaccines market.

The global autogenous vaccines market was valued at US$ 428 Mn in 2018, and is expected to witness a CAGR of 4.4% over the forecast period (2019–2029).

Key Takeaways of Autogenous Vaccines Market Study

  • Bacterial strain type contributes more than 3/4 share in the autogenous vaccines market, owing to increasing rare bacterial infections among livestock and companion animals.
  • Veterinary hospitals account for half of the value share in the global autogenous vaccines market, attributed to increase in the number of veterinary hospitals and rising government funding for animal healthcare.
  • Increasing research activities in the veterinary medicine & biologics industry in the United States and rising animal healthcare expenditure have contributed to the dominance of North America in the global autogenous vaccines market.
  • Attributed to growing awareness regarding zoonotic diseases and increasing funding for animal disease eradication, China, Brazil, and India are expected to offer notable growth opportunities for the autogenous vaccines market.

Starting With The New Decade On A Diligent Note In The Autogenous Vaccines Market?

“Unavailability of licensed vaccines for bacterial and viral infections in animals has directed the focus of several small & large manufactures to invest in the manufacturing of autogenous vaccines, thereby propelling the growth of the autogenous vaccines market,” says a PMR analyst.

Product Portfolio Expansion through Partnerships - Key Strategy of Leading Autogenous Vaccine Manufacturers

Autogenous vaccine manufacturers are focusing on product portfolio expansion through partnerships with and acquisition of small veterinary biologics manufactures.

For example, in 2018, Huvepharma acquired AgriLabs, to expand its presence in the U.S. and speed up the commercialization of biologic products for animal health. The acquisition included AgriLabs's custom vaccines business.

Moreover, in 2017, Pharmgate and Cambridge Technologies entered into a strategic alliance to provide commercial, autogenous, and prescription vaccine solutions to veterinarians.

How About Obtaining Insights About The Region To Enter With Respect To The Autogenous Vaccines Market? Press The “Purchase Now” Button To Have Our Autogenous Vaccines Market Report !

More Valuable Insights on Autogenous Vaccines Market

Persistence Market Research offers a unique perspective and actionable insights on autogenous vaccines in its latest study, presenting historical demand assessment from  2014–2018  and projections for  2019–2029,  on the basis of strain type (bacterial strain and virus strain), and end user (veterinary clinics, veterinary hospitals, and veterinary research institutes), across seven major regions.

Explore Extensive Coverage of Persistence Market Research Life Sciences & Transformational Health Landscape

About Us: -

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers 'experience by acting as the “missing” link between “customer relationships” and “business outcomes'. The best possible returns are assured therein.

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  -
Website  -
blog comments powered by Disqus è un servizio offerto da Factotum Srl